Aceso Plasma Secures $5 Million in Funding for Innovative Oxygen Plasma Device

Aceso Plasma is proud to announce the successful completion of its recent funding round, securing $5 million to further advance its innovative low-temperature, hand-portable plasma device. This groundbreaking technology harnesses the power of oxygen plasma to provide rapid disinfection and accelerated healing for wounds, catering to both in-field medical applications and everyday healthcare needs. The funds will be strategically invested in expanding our research and development initiatives, optimizing the device for enhanced performance, and scaling up our production capabilities to meet growing demand. As the world increasingly prioritizes effective, safe, and portable solutions for wound care, Aceso Plasma stands at the forefront of this critical market, advocating for better health outcomes. This notable funding milestone will also allow us to bolster our marketing efforts, ensuring that medical professionals and consumers alike are aware of the transformative potential that our technology offers. We believe this investment will propel Aceso Plasma to new heights, fostering vital collaborations with healthcare providers while addressing the pressing need for efficient treatment options in both acute and chronic wound management. The journey ahead is filled with immense potential, and we are invigorated by the support we have received from our investors, whose belief in our vision will enable us to save lives and improve patient care worldwide. At Aceso Plasma, we remain committed to innovating the future of wound treatment by leveraging the unique properties of plasma technology, and we are excited to share our progress in the coming months.